Searched over 200M research papers
2 papers analyzed
These studies suggest food does not significantly affect the absorption of metoprolol.
20 papers analyzed
Metoprolol is a beta-blocker commonly prescribed for conditions such as hypertension, angina, and heart failure. Understanding how food affects the absorption and metabolism of metoprolol is crucial for optimizing its therapeutic efficacy and minimizing potential side effects.
Research indicates that the absorption of metoprolol is not significantly affected by food intake. A study involving eight healthy volunteers assessed the plasma concentration-time profiles of metoprolol administered using an Oros drug delivery system under different conditions: after an overnight fast and just before breakfast, lunch, and dinner. The results showed virtually identical plasma concentration-time profiles across all conditions, with no statistically significant differences in mean areas under the curves, peak concentrations, or times to peak. This suggests that metoprolol can be taken with or without food without affecting its absorption.
The systemic availability of metoprolol, as well as the in vivo release and absorption from the Oros system, were found to be unaffected by food. Approximately 80-90% of the absorbed metoprolol reached the systemic circulation within 10 hours, regardless of food intake. Additionally, the ratios of areas under the curve for alpha-hydroxymetoprolol to its parent drug were consistent across all test conditions and similar to those reported after conventional tablet administration.
While food does not significantly impact the absorption of metoprolol, drug-drug interactions can alter its pharmacokinetics. A study examining the interaction between metoprolol and pridopidine, a drug in development for Huntington's disease, found that pridopidine is a metabolism-dependent inhibitor of CYP2D6, the enzyme responsible for metoprolol metabolism. When metoprolol was coadministered with steady-state pridopidine, the exposure to metoprolol increased markedly. The maximum observed plasma concentration and area under the plasma concentration-time curve were significantly higher when metoprolol was taken with pridopidine.
Interestingly, the systemic exposure to pridopidine itself was unaffected by food conditions, indicating that pridopidine can be administered without regard to food. This highlights the importance of considering both food and drug-drug interactions when evaluating the pharmacokinetics of metoprolol.
In summary, the absorption and systemic availability of metoprolol are not significantly influenced by food intake, making it flexible for administration with or without meals. However, drug-drug interactions, such as those with pridopidine, can significantly alter metoprolol's pharmacokinetics, underscoring the need for careful consideration of concomitant medications. Understanding these interactions ensures optimal therapeutic outcomes and patient safety.
Most relevant research papers on this topic